Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ResMed.
RELATED STOCKHEAD STORIES
News
Here are the top ASX large cap movers for Friday
Experts
MoneyTalks: TMS Capital’s Ben Clark says these are the stocks set to grow post-COVID lockdowns
News
Here are the top ASX large cap movers for Thursday
Health & Biotech
ScoPo’s Powerplays: ‘Lots of money on sidelines waiting for pullbacks’, as all eyes are on earnings next week
News
Rise and Shine: What you need to know before the ASX opens
Experts
MoneyTalks: Hyperion’s top ASX stocks look big already, but here’s why they’ve got more room to grow
News
Less miners, more Resmed: T.Rowe Price is overweight Australian equities, but prefers quality over cyclical
Experts
T.Rowe Price: How to shake off the market jitters and position for FY22
Health & Biotech
ScoPo’s Powerplays: ‘Prepare for a big jump in July’ as tax-loss selling in healthcare continues
Experts
Barclay’s bull or Pearce take? Building your portfolio for the post-COVID economy
Experts
MoneyTalks: Have you thought about your stock’s post-COVID environment? If not, this fundie thinks you should
News
Is inflation coming? These are the ASX stocks to buy if yields rise
News
RBA to maintain historic low rates until at least 2024
Experts
ScoPo’s powerplays: Market hit by profit-taking, but healthcare outperforms
Experts
ScoPo’s powerplays: Bullish on mobile X-ray company Micro-X
News
ScoPo’s powerplays: Morgans’ healthcare picks for 2021
News
